Leadership Overview
Themis Medicare has 6 executives leading key functions including strategy, information technology, finance, operations, and international business development.
Driven by a commitment to health, Themis Medicare specializes in manufacturing pharmaceuticals and medicinal chemicals across critical therapeutic areas, impacting patient well-being globally.
Driven by a commitment to health, Themis Medicare specializes in manufacturing pharmaceuticals and medicinal chemicals across critical therapeutic areas, impacting patient well-being globally.
Leadership Roles at Themis Medicare
Rajneesh Anand - Chief Executive Officer
Rajneesh Anand, the Chief Executive Officer at Themis Medicare, directs the company's overall strategic vision and operational execution. Anand guides the organization's expansion within the pharmaceutical and medicinal chemical sectors, focusing on cardiology, pain management, anti-infectives, haematinics, and health and nutrition product lines. This leadership role involves aligning departmental objectives with the company's mission to deliver high-quality healthcare solutions. Overseeing all major business units, Rajneesh Anand ensures that Themis Medicare maintains its competitive edge and upholds stringent quality standards in manufacturing. The Chief Executive Officer's purview extends to fostering innovation and driving sustainable growth across all markets, particularly within India and international territories. Anand's strategic direction is crucial for navigating the complexities of the pharmaceutical industry and achieving long-term corporate goals.
Tushar Dalal - Chief Financial Officer
Tushar Dalal, the Chief Financial Officer at Themis Medicare, manages the company's financial health and strategic fiscal planning. Dalal oversees all financial operations, including budgeting, forecasting, and capital allocation, ensuring robust financial controls and compliance with Indian and international accounting standards. This position is vital for supporting Themis Medicare's manufacturing of pharmaceuticals and medicinal chemicals across its specialized therapeutic areas. Tushar Dalal's financial acumen guides investment decisions, optimizes resource utilization, and enhances profitability. By meticulously managing financial resources, Dalal ensures the company's capacity for sustained growth and innovation in cardiology, pain management, and anti-infectives. The Chief Financial Officer's strategic insights are fundamental to maintaining financial stability and driving shareholder value.
Prakash Naringrekar - Chief Financial Officer & Company Secretary
Prakash Naringrekar, the Chief Financial Officer & Company Secretary at Themis Medicare, provides dual leadership in financial management and corporate governance. Naringrekar oversees the company's financial strategy, ensuring fiscal discipline and compliance with all regulatory mandates, while also managing corporate secretarial duties. This comprehensive role supports Themis Medicare's operations in manufacturing pharmaceuticals and medicinal chemicals for key sectors like cardiology and pain management. Prakash Naringrekar's expertise ensures adherence to legal requirements and best practices in corporate governance, fostering transparency and accountability. By integrating financial oversight with legal compliance, Naringrekar strengthens the company's operational framework. The Chief Financial Officer & Company Secretary's dual focus is essential for maintaining stakeholder confidence and supporting the company's strategic objectives.
Muraridutt Sharma - President
Muraridutt Sharma, the President at Themis Medicare, drives operational excellence and strategic initiatives across key business functions. Sharma oversees the day-to-day management of the company's pharmaceutical manufacturing operations, ensuring efficiency and adherence to quality standards in producing medicinal chemicals for cardiology, pain management, and anti-infectives. This leadership position involves coordinating departmental efforts to achieve corporate objectives and foster a culture of continuous improvement. Muraridutt Sharma's focus on operational effectiveness is critical for maintaining Themis Medicare's market position and expanding its product portfolio. By leading cross-functional teams, Sharma ensures seamless execution of strategies aimed at enhancing health and nutrition offerings. The President's role is pivotal in translating strategic plans into tangible business outcomes.
Hoshang Messman - President, International Business Development
Hoshang Messman, the President, International Business Development at Themis Medicare, spearheads the company's global expansion strategies and market penetration efforts. Messman identifies and cultivates new international opportunities, forging strategic partnerships and expanding distribution networks for Themis Medicare's specialized pharmaceutical products. This role is crucial for driving revenue growth and increasing the company's global footprint in therapeutic areas such as cardiology, pain management, and anti-infectives. Hoshang Messman's expertise in international markets is instrumental in navigating diverse regulatory landscapes and consumer needs. By developing and executing robust international business plans, Messman ensures Themis Medicare effectively reaches new patient populations worldwide. The President, International Business Development's leadership is key to achieving sustained global market success.
Reena Patel - Chief Information Officer
Reena Patel, the Chief Information Officer at Themis Medicare, architects the company's technology infrastructure and digital transformation initiatives. Patel oversees the integration of advanced IT systems to enhance operational efficiency and data security across all manufacturing and distribution processes. This critical role involves managing the company's information assets, ensuring compliance with regulatory requirements, and driving innovation through technology adoption. Reena Patel's leadership ensures that Themis Medicare leverages cutting-edge solutions to support its specialized pharmaceutical manufacturing for cardiology, pain management, and anti-infectives. By optimizing digital workflows, Patel directly contributes to the company's ability to serve its markets effectively. The Chief Information Officer's strategic planning is essential for maintaining a robust and scalable technological foundation that supports business growth and operational excellence.
Explore Leadership Teams in Manufacturing
Founded in 2020, Viatris empowers people worldwide to live healthier at every stage of life. They provide access to medicines, advance sustainable operations, develop innovative solutions, and leverage their collective expertise to improve patient health. Viatris is headquartered in Canonsburg, Pennsylvania.
Company Leadership SP
Founded in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a multinational pharmaceutical, chemical and life sciences company. Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.
Company Leadership GL
JR
Bristol-Myers Squibb operates as a global biopharmaceutical organization dedicated to discovering, developing, and manufacturing prescription medications that address serious patient needs across multiple therapeutic domains. The company's scientific expertise spans oncology, cardiovascular disease, immunoscience, and virology, with particular depth in treating complex conditions including HIV and cancer. Through sustained investment in research and development, the organization has built a comprehensive medication portfolio that combines innovative cancer immunotherapies, anticoagulant therapies, and treatments for chronic viral infections. The company's operational footprint extends across major markets worldwide, enabling efficient distribution and patient access to its therapeutic solutions. Bristol-Myers Squibb pursues a collaborative approach to medical innovation, actively engaging in research partnerships and strategic alliances that accelerate the development of new treatment options. This commitment to external collaboration complements the organization's internal capabilities, creating a dynamic environment where scientific breakthroughs can translate into meaningful therapeutic advances. Bristol-Myers Squibb's medication portfolio reflects decades of pharmaceutical expertise and a strategic focus on disease areas where unmet medical needs remain significant.
Company Leadership MR
BG
BK
JS
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed, and grain processors and processors; meat and poultry processors, seafood processors, fruit and vegetable producers, and dairies; laboratories; and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topical and diagnostic products, rodenticides, cleaners, disinfectants, insecticides, and genomics testing services for the animal safety market. This segment offers various products for researchers to detect biologically active substances. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm and racing animals; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. In addition, this segments products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in Lansing,...
Company Leadership CD
DK
KB